| Authors: |
Goh YS; Singapore Immunology Network, Agency for Science, Technology and Research, Biopolis, Singapore., Necchi F; Sclavo Behring Vaccines Institute for Global Health, a GlaxoSmith Kline Company, Siena, Italy., O'Shaughnessy CM; School of Immunity and Infection, College of Medicine and Dental Sciences, University of Birmingham, Birmingham, United Kingdom., Micoli F; Sclavo Behring Vaccines Institute for Global Health, a GlaxoSmith Kline Company, Siena, Italy., Gavini M; GlaxoSmith Kline, Siena, Italy., Young SP; Centre for Translational Inflammation Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom., Msefula CL; Malawi-Liverpool-Wellcome Trust Clinical Research Programme, College of Medicine, University of Malawi, Blantyre, Malawi.; Department of Pathology, Division of Microbiology, College of Medicine, University of Malawi, Blantyre, Malawi., Gondwe EN; Malawi-Liverpool-Wellcome Trust Clinical Research Programme, College of Medicine, University of Malawi, Blantyre, Malawi.; Department of Basic Medical Sciences, College of Medicine, University of Malawi, Blantyre, Malawi., Mandala WL; Centre for Translational Inflammation Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom., Gordon MA; Department of Gastroenterology, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom., Saul AJ; Sclavo Behring Vaccines Institute for Global Health, a GlaxoSmith Kline Company, Siena, Italy., MacLennan CA; School of Immunity and Infection, College of Medicine and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom. |